+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurodegenerative Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5901485
Description Jump to:
The global neurodegenerative disease treatment market size reached US$ 70.9 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 97.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2022-2028.

Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.

The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication, drug type, route of administration and distribution channel.

Breakup by Indication:

  • Multiple Sclerosis
  • Parkinson’s Disease
  • Alzheimer’s Disease
  • Spinal Muscular Atrophy (SMA)
  • Huntington’s Disease
  • Others

Breakup by Drug Type:

  • N-methyl-D-aspartate Receptor Antagonists
  • Selective Serotonin Reuptake Inhibitors
  • Dopamine Inhibitors
  • Others

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurodegenerative disease treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neurodegenerative Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Multiple Sclerosis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Parkinson’s Disease
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alzheimer’s Disease
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Spinal Muscular Atrophy (SMA)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Huntington’s Disease
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Type
7.1 N-methyl-D-aspartate Receptor Antagonists
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Selective Serotonin Reuptake Inhibitors
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dopamine Inhibitors
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectable
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biogen
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Boehringer Ingelheim International GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 F. Hoffmann-La Roche AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 GlaxoSmithKline Plc
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 Merck & Co. Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Sanofi S.A
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Teva Pharmaceutical Industries Ltd.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 UCB S.A
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2022
Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2022
Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2022
Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players

Companies Mentioned

  • Biogen
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A
  • Teva Pharmaceutical Industries Ltd. and UCB S.A

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages143
PublishedNovember 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 70.9 Billion
Forecasted Market Value ( USD ) by 2028 $ 97.2 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Neurodegenerative Diseases Drugs Market Report and Forecast 2023-2028 - Product Image

Global Neurodegenerative Diseases Drugs Market Report and Forecast 2023-2028

  • Report
  • 188 Pages
  • Global
From
Neurodegenerative Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Neurodegenerative Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Global Market Report 2024 - Product Image

Neurodegenerative Disorder Therapeutics Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Global Neurodegenerative Drugs Market by Drug Class (Cholinesterase Inhibitors, Decarboxylase Inhibitors, Dopamine Agonist), Indication (Alzheimer's Disease, Dementia, Huntington's Disease), Sales Channel - Forecast 2024-2030 - Product Image

Global Neurodegenerative Drugs Market by Drug Class (Cholinesterase Inhibitors, Decarboxylase Inhibitors, Dopamine Agonist), Indication (Alzheimer's Disease, Dementia, Huntington's Disease), Sales Channel - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Neurodegenerative Drugs: Global Strategic Business Report - Product Image

Neurodegenerative Drugs: Global Strategic Business Report

  • Report
  • 344 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.